is there a shortage of tirzepatide FDA ban on compounded tirzepatide: Switch to name brand medications Eli Lilly's Weight-Loss Drug Zepbound

Compared with placebo, tirzepatide 15 mg was the most efficacious treatment in reducing HbA 1c (mean difference 21.61 mmol/mol [1.96%]) followed by tirzepatide 10 mg (20.19 mmol/mol [1.84%]), semaglutide 2.0 mg (17.74 mmol/mol [1.59%]), tirzepatide 5 mg (17.60 mmol/mol [1.60%]), semaglutide 1.0 mg (15.25 mmol/mol [1.39%]) and semaglutide 0.5 mg (12.00 mmol/mol [1.09%])

In the head-to-head SURMOUNT-5 trial, Tirzepatide produced greater weight loss than Semaglutide

Product packaging may differ from what is shown

LRRK2 targeting therapies Leukine-rich repeat kinase 2 (LRRK2) is a member of the Ras-of-complex (ROC) protein family (West 2017)